HOME >> MEDICINE >> NEWS
Reconstruction of the lower jaw with a fibula autotrasplant

This release is also available in Spanish

The University Hospital of the University of Navarra has carried out a complicated surgical operation on a child who had a particularly large benign tumour located in the mandibular region. The procedure involved the extraction of the lower jaw and its substitution by a bone transplant from the fibula of the patient.

The pathology, known as cherubism or familial fibrous dysplasia of the jaws, is a fairly rare condition (although not unheard of) and congenital. It shows itself at about the age of three, usually in males. Multiple benign tumours known as giant cell granulomas - appear on the mandibula and also, on occasions, on the upper jaw. As a consequence, an increase in the size of these bone structures takes place which, in turn, produces facial deformity. In more than 90% of these cases the defect is not particularly noticeable and a normal life can be led; in fact, many scientific articles discard surgery as normally the ailment stabilises on the growth coming to an end.

Infrequent case

The child treated at the University Hospital showed an infrequent case of cherubism. An explosive growth of one or more of the granulomas caused the tumour to reach 10cm diameter and 400gr weight in a few months. After confirming the diagnosis the decision was taken to carry out surgery, given that the infirmity was continuing to evolve, which could have caused serious psychological damage to the child.

The operation involved the extirpation of the mandibula from one end to the other, as it had been completely affected by the tumour. Then a transplant from the fibula bone was substituted, while maintaining the growth factors in the ankle to avoid unwanted consequences for the limb. Unlike a graft, a bone transplant is accompanied by its own artery and vein, and these are joined to arteries and veins in the n
'"/>

Contact: Irati Kortabitarte
iratik@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
9-May-2005


Page: 1 2

Related medicine news :

1. Childhood sun exposure may lower risk of MS
2. 6 out of 10 doctors arent frustrated that patients cant lower cholesterol
3. College students who pull all-nighters and get no sleep more likely to have a lower GPA
4. Exercise lowers insulin in breast cancer survivors
5. Folic acid supplementation lowers stroke risk
6. Intake of vitamin D and calcium associated with lower risk of breast cancer before menopause
7. Coffee consumption may lower blood uric acid levels -- the precursor of gout
8. Moderate drinking lowers womens risk of heart attack
9. Erectile dysfunction and lower urinary tract symptoms
10. Statin use linked with decreased prostate cancer mortality rates, lower PSA levels
11. Grain fiber and magnesium intake associated with lower risk for diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Reconstruction the lower jaw with fibula autotrasplant

(Date:5/20/2013)... comprised over 24,000 Finnish subjects and was led ... a panel of 28 genetic markers improved detection ... disease (CHD) (10-year risk ≥20%) over traditional risk ... important preventive strategy for CHD, because the current ... "The results indicate that genetic markers could be ...
(Date:5/20/2013)... 32nd ESTRO European Cancer Congress will take place ... from Friday 17 September to Tuesday 1 October 2013. ... congress will build on the success of the previous ... Oncology) and ESTRO (European Society for Therapeutic Radiology and ... Europe to offer presentations of cutting-edge research across the ...
(Date:5/20/2013)... FL (PRWEB) May 20, 2013 The producers ... segment dedicated to the essentials of home schooling. It will ... teachers will need to assist children in reaching educational goals. ... the most basic needs in education. Instructors can send tests ... connection to the Web. The celebrity-hosted segment is a top-notch ...
(Date:5/20/2013)... George Town, Grand Cayman, Cayman Islands (PRWEB) May ... City , a knowledge-based, high tech Special Economic ... launch of its Referral Network, an initiative to ... unique concessions combined with Cayman’s business-friendly environment and ... around the world, many of them referrals from ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Dr. Fanny J ... Brilliant, a gentle fractional laser treatment clinically proven to fight ... Clear + Brilliant are designed to prevent and ... + Brilliant can visibly illuminate skin tone, renew and smoothen ... skin, and reduce the appearance of pores. Developed by the ...
Breaking Medicine News(10 mins):Health News:Media registration for the European Cancer Congress 2Health News:Editions TV Presents a Home School Essentials Segment 2Health News:Cayman Enterprise City Introduces Referral Network 2Health News:Cayman Enterprise City Introduces Referral Network 3Health News:Delaware Dermatologist Now Offers Clear + Brilliant Gentle Laser Skin Rejuvenation Treatments 2
(Date:5/20/2013)... CLEVELAND , May 20, 2013 ... the healthcare industry by creating the Multi-Disciplinary Clinical ... a variety of medical experts with diverse healthcare ... the healthcare industry to create new software solutions ... the specific needs of patients and staff. ...
(Date:5/20/2013)... Enrollment of patients with Type 2 diabetes ... trial of product candidate NewMet ™, a delayed-release ... 2 diabetes. Elcelyx expects to complete enrollment of 240 ... of the trial,s primary endpoint of change in fasting ... read-out for long-term glucose lowering and weight benefits is ...
(Date:5/20/2013)... 2013  Rhythm announced today the presentation of results ... of gastroparesis symptoms among diabetic patients in the U.S. ... among patients with both type 1 and type 2 ... with the more common type 2 disease. ... Associate Professor of Medicine at Harvard Medical School and ...
Breaking Medicine Technology:Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 3Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 4
Cached News: